Liu, F., Liu, Y., Liu, X., Mao, K., Zhong, D., Marcus, A. I., . . . Zhou, W. (2018). Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer. Lung Cancer.
Chicago-stil citatLiu, Fakeng, et al. "Inhibition of IGF1R Enhances 2-deoxyglucose in the Treatment of Non-small Cell Lung Cancer." Lung Cancer 2018.
MLA-referensLiu, Fakeng, et al. "Inhibition of IGF1R Enhances 2-deoxyglucose in the Treatment of Non-small Cell Lung Cancer." Lung Cancer 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.